Circulating Biomarker for Liquid Biopsy Market Report

Global and Region Circulating Biomarker for Liquid Biopsy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：161
  • REPORT CODE：GMM892454
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Circulating Biomarker for Liquid Biopsy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Circulating Biomarker for Liquid Biopsymarket, defines the market attractiveness level of Circulating Biomarker for Liquid Biopsy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Circulating Biomarker for Liquid Biopsy industry, describes the types of Circulating Biomarker for Liquid Biopsy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Circulating Biomarker for Liquid Biopsy market and the development prospects and opportunities of Circulating Biomarker for Liquid Biopsy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Circulating Biomarker for Liquid Biopsy market in Chapter 13.

    By Player:

    • Agilent Technologies

    • GE Healthcare

    • Becton, Dickinson and Company

    • Abbott Laboratories

    • Fluxion Biosciences

    • Affymetrix

    • Epigenomics AG

    • Biocept

    By Type:

    • Circulating Tumor Cells (CTCs)

    • Circulating Tumor DNA (ctDNA)

    • Cell-Free DNA (cfDNA)

    • Extracellular Vesicles (EVs)

    • Others

    By End-User:

    • Early Cancer Screening

    • Therapy Selection

    • Treatment Monitoring

    • Recurrence Monitoring Orthopedics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Circulating Biomarker for Liquid Biopsy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Circulating Biomarker for Liquid Biopsy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Circulating Biomarker for Liquid Biopsy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Circulating Biomarker for Liquid Biopsy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Circulating Biomarker for Liquid Biopsy Market Analysis and Outlook to 2022

    • 7.1 Global Circulating Biomarker for Liquid Biopsy Consumption (2017-2022)

    • 7.2 United States Circulating Biomarker for Liquid Biopsy Consumption (2017-2022)

    • 7.3 Europe Circulating Biomarker for Liquid Biopsy Consumption (2017-2022)

    • 7.4 China Circulating Biomarker for Liquid Biopsy Consumption (2017-2022)

    • 7.5 Japan Circulating Biomarker for Liquid Biopsy Consumption (2017-2022)

    • 7.6 India Circulating Biomarker for Liquid Biopsy Consumption (2017-2022)

    • 7.7 South Korea Circulating Biomarker for Liquid Biopsy Consumption (2017-2022)

    8 Region and Country-wise Circulating Biomarker for Liquid Biopsy Market Analysis and Outlook to 2028

    • 8.1 Global Circulating Biomarker for Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.2 United States Circulating Biomarker for Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.3 Europe Circulating Biomarker for Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.4 China Circulating Biomarker for Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.5 Japan Circulating Biomarker for Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.6 India Circulating Biomarker for Liquid Biopsy Consumption Forecast (2022-2028)

    • 8.7 South Korea Circulating Biomarker for Liquid Biopsy Consumption Forecast (2022-2028)

    9 Global Circulating Biomarker for Liquid Biopsy Market Outlook by Types and Applications to 2022

    • 9.1 Global Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Circulating Tumor Cells (CTCs) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Circulating Tumor DNA (ctDNA) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cell-Free DNA (cfDNA) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Extracellular Vesicles (EVs) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Early Cancer Screening Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Therapy Selection Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Treatment Monitoring Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Recurrence Monitoring Orthopedics Consumption and Growth Rate (2017-2022)

    10 Global Circulating Biomarker for Liquid Biopsy Market Outlook by Types and Applications to 2028

    • 10.1 Global Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Circulating Tumor Cells (CTCs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Circulating Tumor DNA (ctDNA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Cell-Free DNA (cfDNA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Extracellular Vesicles (EVs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Early Cancer Screening Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Therapy Selection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Treatment Monitoring Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Recurrence Monitoring Orthopedics Consumption Forecast and Growth Rate (2022-2028)

    11 Global Circulating Biomarker for Liquid Biopsy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Circulating Biomarker for Liquid Biopsy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Circulating Biomarker for Liquid Biopsy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Circulating Biomarker for Liquid Biopsy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Circulating Biomarker for Liquid Biopsy Market Competitive Analysis

    • 14.1 Agilent Technologies

      • 14.1.1 Agilent Technologies Company Details

      • 14.1.2 Agilent Technologies Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Product and Service

    • 14.2 GE Healthcare

      • 14.2.1 GE Healthcare Company Details

      • 14.2.2 GE Healthcare Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Product and Service

    • 14.3 Becton, Dickinson and Company

      • 14.3.1 Becton, Dickinson and Company Company Details

      • 14.3.2 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product and Service

    • 14.4 Abbott Laboratories

      • 14.4.1 Abbott Laboratories Company Details

      • 14.4.2 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product and Service

    • 14.5 Fluxion Biosciences

      • 14.5.1 Fluxion Biosciences Company Details

      • 14.5.2 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product and Service

    • 14.6 Affymetrix

      • 14.6.1 Affymetrix Company Details

      • 14.6.2 Affymetrix Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Affymetrix Circulating Biomarker for Liquid Biopsy Product and Service

    • 14.7 Epigenomics AG

      • 14.7.1 Epigenomics AG Company Details

      • 14.7.2 Epigenomics AG Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Product and Service

    • 14.8 Biocept

      • 14.8.1 Biocept Company Details

      • 14.8.2 Biocept Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Biocept Circulating Biomarker for Liquid Biopsy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Circulating Biomarker for Liquid Biopsy

    • Figure Circulating Biomarker for Liquid Biopsy Picture

    • Table Global Circulating Biomarker for Liquid Biopsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Biomarker for Liquid Biopsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Biomarker for Liquid Biopsy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Circulating Biomarker for Liquid Biopsy Consumption by Country (2017-2022)

    • Figure United States Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Table Europe Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure China Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure Japan Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure India Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Circulating Biomarker for Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Biomarker for Liquid Biopsy Consumption Forecast by Country (2022-2028)

    • Figure United States Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Circulating Biomarker for Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Circulating Tumor Cells (CTCs) Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor DNA (ctDNA) Consumption and Growth Rate (2017-2022)

    • Figure Global Cell-Free DNA (cfDNA) Consumption and Growth Rate (2017-2022)

    • Figure Global Extracellular Vesicles (EVs) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Early Cancer Screening Consumption and Growth Rate (2017-2022)

    • Figure Global Therapy Selection Consumption and Growth Rate (2017-2022)

    • Figure Global Treatment Monitoring Consumption and Growth Rate (2017-2022)

    • Figure Global Recurrence Monitoring Orthopedics Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor Cells (CTCs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Circulating Tumor DNA (ctDNA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell-Free DNA (cfDNA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Extracellular Vesicles (EVs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Early Cancer Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapy Selection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treatment Monitoring Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recurrence Monitoring Orthopedics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Circulating Biomarker for Liquid Biopsy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Circulating Biomarker for Liquid Biopsy Export by Region (Top 5 Countries) (2017-2028)

    • Table Agilent Technologies (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Circulating Biomarker for Liquid Biopsy Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Circulating Biomarker for Liquid Biopsy Product and Service

    • Table Becton, Dickinson and Company (Foundation Year, Company Profile and etc.)

    • Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product and Service

    • Table Fluxion Biosciences (Foundation Year, Company Profile and etc.)

    • Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product and Service

    • Table Affymetrix (Foundation Year, Company Profile and etc.)

    • Table Affymetrix Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Affymetrix Circulating Biomarker for Liquid Biopsy Product and Service

    • Table Epigenomics AG (Foundation Year, Company Profile and etc.)

    • Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Product and Service

    • Table Biocept (Foundation Year, Company Profile and etc.)

    • Table Biocept Circulating Biomarker for Liquid Biopsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocept Circulating Biomarker for Liquid Biopsy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US